Nektar Therapeutics | NKTR - 資産





資産 変化する 日付
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 96.05B 409M 2026-09
Baxter International USD 19.41B 377M 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cipla INR 434.34B 9.38B 2026-09
Dr.Reddys Laboratories INR 576.31B 1.01B 2026-09
Eisai JPY 1.52T 33.49B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Exelixis USD 2.51B 19.26M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Ironwood Pharmaceuticals USD 290.59M 5.46M 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 318.68M 26.72M 2026-09
Merck USD 132.77B 2.97B 2026-09
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Takeda JPY 15.27T 391.77B 2026-09
Teva Pharmaceutical Industries USD 40.04B 185M 2026-09
Xencor USD 770.5M 45.54M 2026-09